Analgesics (Pharmacies) - Bulgaria

  • Bulgaria
  • Revenue in the Analgesics market is projected to reach US$138.70m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 6.51%, resulting in a market volume of US$190.10m by 2029.
  • In global comparison, most revenue will be generated in China (US$5,028.00m in 2024).
  • In relation to total population figures, per person revenues of US$20.95 are generated in 2024.

Key regions: China, South Korea, Canada, India, France

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Analgesics (Pharmacies) market in Bulgaria has been experiencing steady growth in recent years. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors have all contributed to this development. Customer preferences in the Analgesics (Pharmacies) market in Bulgaria have been shifting towards a preference for over-the-counter (OTC) pain relief medications. This is driven by the convenience and accessibility of purchasing these products without a prescription. Customers are also increasingly seeking out analgesics that offer fast and effective relief, as well as those with fewer side effects. This has led to a growing demand for innovative and advanced analgesic products in the market. Trends in the market indicate a growing focus on natural and herbal analgesics in Bulgaria. Customers are becoming more health-conscious and are seeking out alternative forms of pain relief that are perceived as safer and more sustainable. As a result, there has been an increase in the availability and popularity of natural analgesic products in pharmacies across the country. Additionally, there is a growing trend of online purchasing of analgesics, as customers are increasingly turning to e-commerce platforms for their healthcare needs. Local special circumstances in Bulgaria have also contributed to the development of the Analgesics (Pharmacies) market. The country has a well-developed healthcare system, with a strong network of pharmacies that provide easy access to analgesic products. Furthermore, the government has implemented regulations to ensure the safety and quality of pharmaceutical products, which has fostered consumer trust in the market. These factors have created a favorable environment for the growth of the Analgesics (Pharmacies) market in Bulgaria. Underlying macroeconomic factors have also played a role in the development of the market. Bulgaria has experienced stable economic growth in recent years, which has contributed to increased disposable income and consumer spending. As a result, consumers have more purchasing power to buy analgesic products. Additionally, the aging population in Bulgaria has contributed to the growth of the market, as older individuals are more likely to experience chronic pain and require analgesic medications. In conclusion, the Analgesics (Pharmacies) market in Bulgaria is developing due to shifting customer preferences towards OTC medications, the growing demand for natural and herbal analgesics, the convenience of online purchasing, a well-developed healthcare system, government regulations, stable economic growth, and an aging population. These factors have created a favorable environment for the growth of the market in Bulgaria.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)